SEPN
SEPN
NASDAQ · Pharmaceuticals

Septerna Inc

$24.37
+0.39 (+1.63%)
As of May 9, 1:37 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +84.5% upside
Low Target $33.78
Average Target $44.96
High Target $58.81
Current Price $24.37
Current
$24.37
Target
$44.96
$33.78 $44.96 avg $58.81
Scenario Analysis
Bear Case
$33.78
38.6%
Low target
Base Case
$44.96
+84.5%
Avg target
Bull Case
$58.81
+141.3%
High target
Risk/Reward
3.7x
Highly favorable
Price in Context
52-Week High
$32.63
-25.3% from high
52-Week Low
$6.44
+278.4% from low
Target vs 52W High
$44.96
+37.8% vs high
Next Earnings Report
May 14, 2026
3d
until earnings
EPS Est: $-0.37
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%